Literature DB >> 17293379

Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms.

Ryoichi Fujiwara1, Miki Nakajima, Hiroyuki Yamanaka, Akiko Nakamura, Miki Katoh, Shin-ichi Ikushiro, Toshiyuki Sakaki, Tsuyoshi Yokoi.   

Abstract

We established stable HEK293 cell lines expressing double isoforms, UGT1A1 and UGT1A9, UGT1A4 and UGT1A9, or UGT1A6 and UGT1A9, as well as stable cell lines expressing each single isoform. To analyze the protein-protein interaction between the UGT1As, we investigated the thermal stability and resistance to detergent. UGT1A9 uniquely demonstrated thermal stability, which was enhanced in the presence of UDP-glucuronic acid (>90% of control), and resistance to detergent. Interestingly, UGT1A1, UGT1A4, and UGT1A6 acquired thermal stability and resistance to detergent by the coexpression of UGT1A9. An immunoprecipitation assay revealed that UGT1A6 and UGT1A9 interact in the double expression system. Using the single expression systems, it was confirmed that estradiol 3-O-glucuronide, imipramine N-glucuronide, serotonin O-glucuronide, and propofol O-glucuronide formations are specific for UGT1A1, UGT1A4, UGT1A6, and UGT1A9, respectively. By kinetic analyses, we found that the coexpressed UGT1A9 significantly affected the kinetics of estradiol 3-O-glucuronide formation (decreased Vmax), imipramine N-glucuronide formation (increased Km and Vmax), and serotonin O-glucuronide formation (decreased Vmax) catalyzed by UGT1A1, UGT1A4, and UGT1A6, respectively. On the other hand, the coexpressed UGT1A1 increased Km and decreased the Vmax of the propofol O-glucuronide formation catalyzed by UGT1A9. The coexpressed UGT1A4 and UGT1A6 also increased the Vmax of the propofol O-glucuronide formation by UGT1A9. This is the first study showing that human UGT1A isoforms interact with other isoforms to change the enzymatic characteristics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293379     DOI: 10.1124/dmd.106.014191

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

1.  UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.

Authors:  Wen Jiang; Beibei Xu; Baojian Wu; Rong Yu; Ming Hu
Journal:  Drug Metab Dispos       Date:  2011-11-09       Impact factor: 3.922

2.  Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice.

Authors:  Yuki Kutsuno; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

3.  Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).

Authors:  Jin Zhou; Upendra A Argikar; John O Miners
Journal:  Methods Mol Biol       Date:  2021

4.  Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemia.

Authors:  Kyohei Sumida; Makiko Kawana; Emi Kouno; Tomoo Itoh; Shuhei Takano; Tomoya Narawa; Robert H Tukey; Ryoichi Fujiwara
Journal:  Mol Pharmacol       Date:  2013-08-15       Impact factor: 4.436

Review 5.  Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans.

Authors:  Ryoichi Fujiwara; Emiko Yoda; Robert H Tukey
Journal:  Drug Metab Pharmacokinet       Date:  2017-10-07       Impact factor: 3.614

6.  Evaluation of UGT protein interactions in human hepatocytes: effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes.

Authors:  Camille M Konopnicki; Leslie J Dickmann; Jeffrey M Tracy; Robert H Tukey; Larry C Wienkers; Robert S Foti
Journal:  Arch Biochem Biophys       Date:  2013-04-04       Impact factor: 4.013

Review 7.  Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia.

Authors:  Ryoichi Fujiwara; Yoshihiro Maruo; Shujuan Chen; Robert H Tukey
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-02       Impact factor: 4.219

8.  Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.

Authors:  Linlin Lu; Juan Zhou; Jian Shi; Xiao-juan Peng; Xiao-xiao Qi; Ying Wang; Fang-Yuan Li; Fu-Yuan Zhou; Liang Liu; Zhong-Qiu Liu
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

9.  Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes.

Authors:  Yuki Kutsuno; Kyohei Sumida; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2013-09-03

10.  Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia.

Authors:  Ayako Shibuya; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Sci Rep       Date:  2013-10-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.